Fresenius Medical Care AG & Co. KGaA

  • WKN: 578580
  • ISIN: DE0005785802
  • Land: Deutschland

Nachricht vom 27.04.2012 | 18:03

Fresenius Medical Care AG & Co. KGaA: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution


Fresenius Medical Care AG & Co. KGaA 

27.04.2012 18:03

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


On April 25, 2012, BlackRock, Inc., New York, USA has informed us according
to Article 21, Section 1 of the WpHG that via shares its voting rights on
Fresenius Medical Care AG & Co. KGaA, Bad Homburg, Germany, ISIN:
DE0005785802, WKN: 578580 have fallen below the 5% threshold of the voting
rights on April 19, 2012 and on that day amounted to 4.99% (this
corresponds to 14974211 voting rights).
According to Article 22, Section 1, Sentence 1, No. 6 in connection with
sentence 2 of the WpHG, 4.99% of the voting rights (this corresponds to
14974211 voting rights) is to be attributed to the company.
 



27.04.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
Internet:     www.fmc-ag.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Event im Fokus

38. m:access Analystenkonferenz München

Datum: 06.06.2013
Zeit: 9:30 Uhr - 17.00 Uhr
Ort: Börse München



Aktuelle Research-Studie

Analytik Jena AG

Original-Research: Analytik Jena AG (von Montega AG): Kaufen

23. Mai 2013